top of page

ASCO 2026: Nanobiotix's approach to boosting the efficacy of radiation therapy is in a P3 head & neck trial that JNJ is leading, and they are expecting a key P2 readout in lung before it as well

  • 9 hours ago
  • 1 min read

CEO Laurent Lévy walks us through the phase 3 trial's progress, and the reason why the trial protocol was recently changed. Plus, how this nano approach is looking in other cancers, and how Nanobiotix is also trying to help make LNP delivered medicines have wider utility.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page